Relmada Therapeutics

RLMD
3.2700.61% ( -0.020 )
已收盘: 10月23日 16:00:00 (美东)

全部股东

股东类型

  • 机构投资者75.04%
  • 对冲基金12.88%
  • 风投/私募6.42%
  • 个人与内部人士3.23%
  • 公众及其他2.43%

主要股东

主要股东 最新
股东
Janus Henderson Group Ltd.
10.47%1,116.48 万0.08%+10.09 万
BlackRock, Inc.
6.96%742.68 万5.73%+613.72 万
Squadron Capital Management LLC
6.89%735.00 万1.19%-112.46 万
VR Management, LLC
6.42%684.43 万1.80%+200.09 万
Spruce Street Capital LP
5.99%639.13 万0.02%+12.92 万
Vanguard Capital Management, LLC
4.87%519.44 万1.51%+166.80 万
Adage Capital Management, L.P.
4.47%476.32 万0.08%+0
Jones Hill Capital LP
3.43%365.51 万3.10%+331.23 万
OrbiMed Advisors LLC
3.40%363.12 万1.09%-108.47 万
State Street Investment Management
2.36%251.76 万2.02%+216.05 万
Geode Capital Management, LLC
2.34%249.26 万1.53%+164.39 万
Millennium Management LLC
2.21%236.18 万1.51%-154.54 万
Marshall Wace LLP
2.11%224.68 万2.17%-223.48 万
Ikarian Capital, LLC
2.01%214.84 万0.55%-54.00 万
Driehaus Capital Management LLC
2.00%213.21 万0.03%+0
Columbia Management Investment Advisers, LLC
1.82%193.80 万0.30%+34.70 万
Eventide Asset Management, LLC
1.74%185.84 万0.94%+101.63 万
Balyasny Asset Management L.P.
1.43%152.07 万1.18%+126.82 万
Sergio TraversaCEO & Director
1.41%150.00 万0.19%+20.00 万
StemPoint Capital LP
1.37%146.01 万0.80%+86.27 万